Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026
Key Highlights
- ➤Myriad Genetics (MYGN) will release third quarter 2026 results November 4 after market close
- ➤Third quarter 2026 earnings conference call begins November 4 at 4:30 pm ET
- ➤Management will provide a financial overview and business update during the conference call
SALT LAKE CITY, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third quarter 2026 earnings conference call at 4:30 pm ET on Wednesday, November 4, 2026. The company’s quarterly earnings will be released the same day after market close. During the call, Myriad management will provide a financial overview and business update of the company’s performance for the third quarter 2026.
A live webcast of the conference call can be accessed on Myriad’s Investor Relations website at investor.myriad.com. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An archived webcast of the call will be available at investor.myriad.com following the call.
Get started
Create a free account to read the full story.